On January 1, 2020, Eidos Therapeutics, Inc. appointed Franco Valle as the company’s Senior Vice President, Finance and principal accounting officer, effective immediately. Mr. Valle succeeds Christine Siu as the company’s principal accounting officer. Mr. Valle joined the company as its Vice President, Finance in March, 2018. Before he joined the company from July 2016 to January 2018 he worked at Iovance Biotherapeutics, Inc. as the Controller and principal accounting officer. Prior thereto, from May 2012 through April 2016 Mr. Valle worked at Pharmacyclics, Inc. in various positions, including most recently as the senior director of accounting. Prior thereto, Mr. Valle was the SEC reporting manager of Callidus Software, Inc. from October 2011 to May 2012. From July 2005 to October 2011, Mr. Valle worked at PricewaterhouseCoopers LLP in the life science, biotech and venture capital group.